Realyze Intelligence has filed a notice of an exempt offering of securities to raise $4,000,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Realyze Intelligence is raising $4,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Aaron Brauser played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Realyze Intelligence
Realyze Intelligence is a technology solution that delivers Clinical Intelligence, which mimics how a clinician understands patients notes. Using a combination of Natural Language Understanding (NLU) and Artificial Intelligence-based inference, this Clinical Intelligence understands the meaning and intent in patient documentation. Realyzes general-purpose platform facilitates acquiring the narrative data and creating a comprehensive patient story for multipurpose use. This infrastructure enables reuses of its core clinical understanding, rapidly addressing many clinical scenarios and delivering results quickly. Realyze is currently being used at UPMC, one of the largest health systems in the nation, for a variety of applications including revenue optimization, improving patient care, and clinical research.
To learn more about Realyze Intelligence, visit http://realyzeintelligence.com/
Contact:
Aaron Brauser, Chief Executive Officer
412-864-4942
https://www.linkedin.com/in/abrauser/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.